Upstate Active Clinical Trials
Study Title:A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Infants
What is the purpose of the study? (in Layman's terms, please describe the study)The purpose of this study is to:
• Test how safe the vaccine is and how well your child can tolerate the research study vaccine, V114, compared to Prevnar 13.
• Test how much the body can respond the study vaccine, V114.
Upstate Institutional Review Board (IRB) Number:983081
Study Phase:Phase III
Patient Age Group:Children
Principal Investigator:Leonard B Weiner
Who can I contact for more information?
Name: Kristen Fluno